• Optimizing Cancer Assays with Romidepsin (FK228, depsipeptid

  2026-06-03

  This article guides biomedical researchers through real-world challenges in cell viability, proliferation, and cytotoxicity workflows, spotlighting Romidepsin (FK228, depsipeptide), SKU A8173. Drawing on quantitative data and literature, it demonstrates how this HDAC inhibitor advances reproducibility and sensitivity in epigenetic and oncology research.

• HOBt (1-Hydroxybenzotriazole): Precision in Peptide Synthesi

  2026-06-03

  HOBt (1-Hydroxybenzotriazole) is a benchmark reagent for minimizing epimerization during peptide synthesis and amide bond formation. Its high purity and proven mechanism make it indispensable for workflows that demand stereochemical integrity and reproducibility.

• Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor in Metabo

  2026-06-02

  Sitagliptin phosphate monohydrate stands out as a selective DPP-4 inhibitor, empowering metabolic research with precision incretin modulation and reproducible workflows. Explore its applied use in glucose homeostasis models, robust protocol design, and troubleshooting techniques that maximize data fidelity.

• 7ACC2 as an MCT1 Inhibitor: Unraveling Tumor Immunometabolic

  2026-06-02

  Explore how 7ACC2, a potent monocarboxylate transporter 1 inhibitor, enables advanced studies of tumor immunometabolism by targeting lactate and pyruvate flux. This in-depth analysis reveals new insights and strategic applications for cancer progression research.

• JHU-083: Protocol-Driven Advances in Glutaminase Pathway Res

  2026-06-01

  JHU-083 empowers targeted glutaminase inhibition in neurological and experimental cerebral malaria research, translating bench chemistry into actionable models for glutamate excitotoxicity and oxidative stress. This article delivers hands-on protocols, troubleshooting guidance, and cross-study insights to maximize experimental reliability using this 6-diazo-5-oxo-L-norleucine precursor.

• EdU Imaging Kits (Cy3): Enabling High-Fidelity Cell Prolifer

  2026-06-01

  EdU Imaging Kits (Cy3) transform cell proliferation analysis by leveraging denaturation-free, click chemistry-based detection of S-phase DNA synthesis. Optimized for both fluorescence microscopy and flow cytometry, these kits empower researchers to resolve complex proliferation dynamics and genotoxicity with unmatched sensitivity and workflow efficiency.

• Cardiogreen (Indocyanine Green): Mechanisms Driving Translat

  2026-05-31

  Explore how Cardiogreen (Indocyanine Green) empowers translational researchers with mechanistic precision for diagnostics and immunogenic phototherapies. This article bridges emerging evidence on photothermal-CD47 blockade synergy with practical protocol insights, situating Cardiogreen at the forefront of vascular imaging and cancer immunotherapy innovation.

• Sodium Ascorbate: Mechanism and Evidence in Glioblastoma Res

  2026-05-30

  Sodium Ascorbate, a mineral salt of ascorbic acid, offers enhanced bioavailability and induces reactive oxygen species, leading to necrotic tumor cell death. This article presents verifiable evidence supporting its application in glioblastoma research and clarifies boundaries for its experimental use.

• Gefitinib (ZD1839): Elevating EGFR Inhibition in Complex Tum

  2026-05-29

  This thought-leadership article explores the mechanistic and translational significance of Gefitinib (ZD1839) for EGFR signaling pathway inhibition and apoptosis induction in cancer cells. Drawing on the latest advances in assembloid modeling and recent patient-derived gastric cancer studies, we outline evidence-led best practices, strategic guidance for translational researchers, and a forward-looking perspective on personalized oncology.

• Dextromethorphan hydrobromide: Reliable NMDA Antagonist for

  2026-05-29

  This article examines practical laboratory challenges in neuroprotection research and demonstrates how Dextromethorphan hydrobromide (SKU B3478) from APExBIO offers reproducible, high-purity solutions. Scenario-driven Q&A blocks address assay consistency, reagent compatibility, and data interpretation, supporting workflow reliability for cell viability and excitotoxicity studies.

• Applied Workflows with 2-(4,5,6,7-tetrabromo...) Small Molec

  2026-05-28

  The CK2 and ERK8 inhibitor showcases exceptional versatility as a small molecule inhibitor for dissecting kinase-regulated pathways and LLPS-driven processes in cell biology. This article delivers workflow-centric guidance, data-driven troubleshooting, and cross-domain insights for harnessing this APExBIO reagent in advanced enzyme and protein interaction research.

• PAD4-IN-2 TFA: Selective PAD4 Inhibition for Tumor Research

  2026-05-28

  PAD4-IN-2 TFA (Compound 5i TFA) is a meta-phenylboronic acid-modified, highly selective PAD4 inhibitor with proven efficacy in inhibition of histone H3 citrullination, suppression of neutrophil extracellular trap (NET) formation, and modulation of the tumor immune microenvironment. It achieves tumor-targeted delivery, strong antitumor activity, and favorable safety in vivo, as verified by peer-reviewed studies and product documentation.

• ONX-0914 (PR-957): Synaptic Plasticity, Immune Modulation, a

  2026-05-27

  Explore the multifaceted roles of ONX-0914 (PR-957) in immunoproteasome inhibition, synaptic plasticity, and autoimmune research. This in-depth review integrates novel CNS findings and practical assay guidance, offering insights that go beyond conventional cytokine blockade.

• MDL 28170: Advancing Calpain Inhibition in Translational Res

  2026-05-27

  This thought-leadership article explores the mechanistic, experimental, and translational dimensions of MDL 28170—a highly selective calpain and cathepsin B inhibitor—positioning it as a pivotal tool for researchers tackling neurodevelopmental injury, apoptosis, and ischemia-reperfusion models. Integrating recent evidence on BDNF/TrkB pathway rescue and rigorous protocol recommendations, it delivers actionable guidance for elevating research fidelity and clinical relevance.

• Optimizing Reporter Assays with EZ Cap™ Firefly Luciferase m

  2026-05-26

  Explore how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) (SKU R1013) addresses key challenges in cell-based bioluminescent assays, delivering high reproducibility, sensitivity, and workflow safety. This article uses real-world laboratory scenarios to demonstrate its validated performance and practical advantages for mRNA delivery, translation efficiency, and cell viability studies.

11392 records 7/760 page Previous Next First page 上5页 678910 下5页 Last page